MedPath

National Heart, Lung, and Blood Institute

National Heart, Lung, and Blood Institute logo
πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Establishing a Repository of Blood and DNA Samples From People With Sickle Cell Disease (Comprehensive Sickle Cell Centers Collaborative Genotype-Phenotype Database and Sample Repository)

Terminated
Conditions
Anemia, Sickle Cell
First Posted Date
2007-09-12
Last Posted Date
2016-07-12
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
3640
Registration Number
NCT00528203
Locations
πŸ‡ΊπŸ‡Έ

Brigham & Women's Hospital, Boston, Massachusetts, United States

πŸ‡ΊπŸ‡Έ

Children's Hospital of Boston, Boston, Massachusetts, United States

πŸ‡ΊπŸ‡Έ

Children's Hospital Oakland, Oakland, California, United States

and more 10 locations

Role of Nitric Oxide in Malaria

Completed
Conditions
Malaria
Pulmonary Hypertension
First Posted Date
2007-09-10
Last Posted Date
2019-12-16
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
103
Registration Number
NCT00527163
Locations
πŸ‡²πŸ‡±

Hospital Gabriel Toure, Bamako, Mali

Niacin to Improve Blood Flow in People With Sickle Cell Disease

Phase 2
Completed
Conditions
Sickle Cell Disease
Interventions
Drug: Placebo
Drug: Niacin-ER
First Posted Date
2007-07-30
Last Posted Date
2020-09-10
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
30
Registration Number
NCT00508989
Locations
πŸ‡ΊπŸ‡Έ

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

πŸ‡ΊπŸ‡Έ

Howard University Hospital, Washington, District of Columbia, United States

Effectiveness of an Anger and Stress Management Program on Reducing Blood Pressure Levels in Youth

Phase 2
Completed
Conditions
Hypertension
Cardiovascular Diseases
Interventions
Behavioral: Williams LifeSkills Stress and Anger Management Workshop
Behavioral: High school classes
First Posted Date
2007-07-30
Last Posted Date
2016-07-12
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
259
Registration Number
NCT00508612
Locations
πŸ‡ΊπŸ‡Έ

Medical College of Georgia - Georgia Prevention Institute, Augusta, Georgia, United States

πŸ‡ΊπŸ‡Έ

Richmond County Board of Education Public Schools, Augusta, Georgia, United States

πŸ‡ΊπŸ‡Έ

Williams LifeSkills, Durham, North Carolina, United States

Genes Causing Ebstein's Anomaly

Completed
Conditions
Heart Septal Defects, Ventricle
Double Outlet Right Ventricle
Heart Defects, Congenital
Truncus Arteriosus, Persistent
First Posted Date
2007-07-09
Last Posted Date
2017-07-02
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00497705
Locations
πŸ‡ΊπŸ‡Έ

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

πŸ‡ΊπŸ‡¦

Amosov Institute of Cardiovascular Surgery, Kyiv, Ukraine

πŸ‡§πŸ‡Ύ

Republican Scientific and Clinical Cardiology Center, Republic of Belarus, Belarus

Pulmonary Hypertension, Hypoxia and Sickle Cell Disease

Completed
Conditions
Pulmonary Hypertension
Sickle Cell Anemia
Chuvash Polycythemia
Cerebrovascular Disease
First Posted Date
2007-07-03
Last Posted Date
2019-12-16
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
29
Registration Number
NCT00495638
Locations
πŸ‡ΊπŸ‡Έ

Baylor College of Medicine, Houston, Texas, United States

πŸ‡ΊπŸ‡Έ

Childrens National Medical Center, Washington, District of Columbia, United States

πŸ‡ΊπŸ‡Έ

Howard University Hospital, Washington, District of Columbia, United States

and more 4 locations

Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease

Phase 2
Terminated
Conditions
Sickle Cell Disease
Pulmonary Hypertension
Interventions
Drug: Placebo
First Posted Date
2007-06-27
Last Posted Date
2016-01-06
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
74
Registration Number
NCT00492531
Locations
πŸ‡ΊπŸ‡Έ

University of Colorado, Denver, Colorado, United States

πŸ‡ΊπŸ‡Έ

University of Illinois at Chicago, Chicago, Illinois, United States

πŸ‡¬πŸ‡§

Imperial College London and Hammersmith Hospital, London, United Kingdom

and more 6 locations

Peptide Vaccinations to Treat Patients With Low-Risk Myeloid Cancers

Phase 2
Completed
Conditions
Acute Myeloid Leukemia (AML)
Chronic Myeloid Leukemia (CML)
Myelodysplastic Syndrome (MDS)
Interventions
Biological: Montanide adjuvant
First Posted Date
2007-06-20
Last Posted Date
2021-07-12
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
10
Registration Number
NCT00488592
Locations
πŸ‡ΊπŸ‡Έ

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Cardiovascular Disease Screening

Terminated
Conditions
Atherosclerosis
Myocardial Infarction
Acquired Heart Disease
Congenital Heart Disease
Myocardial Ischemia
Interventions
Device: Toshiba Aquilion ONE CT
Device: SWiemens MRI scanner
First Posted Date
2007-06-08
Last Posted Date
2021-07-29
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
1325
Registration Number
NCT00483951
Locations
πŸ‡ΊπŸ‡Έ

Suburban Hospital, Bethesda, Maryland, United States

πŸ‡ΊπŸ‡Έ

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Childhood Asthma Research and Education (CARE) Network Trial - Montelukast or Azithromycin for Reduction of Inhaled Corticosteroids in Childhood Asthma (MARS)

Phase 4
Terminated
Conditions
Asthma
First Posted Date
2007-05-10
Last Posted Date
2016-07-29
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
210
Registration Number
NCT00471809
Locations
πŸ‡ΊπŸ‡Έ

University of Arizona College of Medicine, Tucson, Arizona, United States

πŸ‡ΊπŸ‡Έ

Los Angeles, Kaiser Permanente Allergy Department, Los Angeles, California, United States

πŸ‡ΊπŸ‡Έ

University of Wisconsin - Madison, Madison, Wisconsin, United States

and more 3 locations
Β© Copyright 2025. All Rights Reserved by MedPath